search
Back to results

To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic (Coronavirus19)

Primary Purpose

TB - Tuberculosis, Patient Satisfaction

Status
Unknown status
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
Patient-centred advice on Telephone Consultation in TB Patients:
Sponsored by
Health Science Center of Xi'an Jiaotong University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for TB - Tuberculosis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

New, smear-positive drug-susceptible TB who have been on treatment for less than two weeks Access to a mobile phone (self-reported)

Exclusion Criteria:

Patients who do not have regular access to a mobile phone Patients who have previously received TB treatment Patients who have another member in their household who is already a part of the study

Sites / Locations

  • Dhq Bannu KpkRecruiting
  • District Bannu TB Control CenterRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Telephone Consultation in TB Patients

Arm Description

The COVID-19 pandemic might be an opportunity to review and refine our practices in TB care. For the follow-up of selected patients, telephone consultations may be efficient and cost-effective.

Outcomes

Primary Outcome Measures

Efficiency of the telephone consultation,
To improve patient centered care/patient prescription refill
Patient satisfaction
Patient satisfaction Patient satisfaction resulting from pharmacist-led pharmaceutical care will be assessed Patient satisfaction feedback (PSF)

Secondary Outcome Measures

Adherence Rate

Full Information

First Posted
May 30, 2020
Last Updated
November 16, 2020
Sponsor
Health Science Center of Xi'an Jiaotong University
Collaborators
Pakistan Institute of Medical Sciences Islamabad Pakistan, District Headquarter Hospital Bannu Pakistan
search

1. Study Identification

Unique Protocol Identification Number
NCT04412239
Brief Title
To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic
Acronym
Coronavirus19
Official Title
To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Unknown status
Study Start Date
April 20, 2020 (Actual)
Primary Completion Date
December 20, 2020 (Anticipated)
Study Completion Date
December 20, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Health Science Center of Xi'an Jiaotong University
Collaborators
Pakistan Institute of Medical Sciences Islamabad Pakistan, District Headquarter Hospital Bannu Pakistan

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The COVID-19 pandemic might be an opportunity to review and refine our practices in anti TB treatment. For the follow-up of selected patients, telephone consultations may be efficient and cost-effective. The aim of the study is to assess the efficiency and the satisfaction with telephone consultation for the pharmacist and the TB patient. The study was conducted in tertiary care hospital TB control centres patients.
Detailed Description
Tuberculosis (TB) is the world's biggest killer among infectious diseases, claiming more than 4000 lives each day. The unprecedented coronavirus pandemic seriously impacts people with pre-existing health conditions. People who have TB are usually more vulnerable to other infections, including the novel coronavirus, due to pre-existing lung damage. They are at a higher risk of developing complications from COVID-19. Certain populations are at greater risk of TB, because of where they live, where they work or because of other socio-economic factors which result in them experiencing barriers to accessing health services.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
TB - Tuberculosis, Patient Satisfaction

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Telephone Consultation in TB Patients
Arm Type
Experimental
Arm Description
The COVID-19 pandemic might be an opportunity to review and refine our practices in TB care. For the follow-up of selected patients, telephone consultations may be efficient and cost-effective.
Intervention Type
Behavioral
Intervention Name(s)
Patient-centred advice on Telephone Consultation in TB Patients:
Intervention Description
The primary aim was to assess the efficiency and the satisfaction of the telephone consultation. The COVID-19 pandemic might be an opportunity to review and refine our practices in TB care. For the follow-up of selected patients, telephone consultations may be efficient and cost effective.
Primary Outcome Measure Information:
Title
Efficiency of the telephone consultation,
Description
To improve patient centered care/patient prescription refill
Time Frame
2 Months
Title
Patient satisfaction
Description
Patient satisfaction Patient satisfaction resulting from pharmacist-led pharmaceutical care will be assessed Patient satisfaction feedback (PSF)
Time Frame
2 Month
Secondary Outcome Measure Information:
Title
Adherence Rate
Time Frame
2 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: New, smear-positive drug-susceptible TB who have been on treatment for less than two weeks Access to a mobile phone (self-reported) Exclusion Criteria: Patients who do not have regular access to a mobile phone Patients who have previously received TB treatment Patients who have another member in their household who is already a part of the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Farman Ul Khan, Master
Phone
003319443131
Email
farmankhan@bs.qau.edu.pk
First Name & Middle Initial & Last Name or Official Title & Degree
Yu Fang, Phd
Email
yufang@xjtu.edu.cn
Facility Information:
Facility Name
Dhq Bannu Kpk
City
Bannu
State/Province
KPK
ZIP/Postal Code
2800
Country
Pakistan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Farman Ull ah Khan
Phone
+92331-3319443131
Email
farmankhan@bs.qau.pk
Facility Name
District Bannu TB Control Center
City
Bannu
State/Province
KPK
ZIP/Postal Code
2800
Country
Pakistan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Asif Ul Khan, Master
Phone
0092334087008
Email
asifkhanustb@gmail.com
First Name & Middle Initial & Last Name & Degree
Farman Ul Khan, Master
First Name & Middle Initial & Last Name & Degree
Yu Fang, Phd

12. IPD Sharing Statement

Learn more about this trial

To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic

We'll reach out to this number within 24 hrs